Cite Filings / CAMP / 0001415889-25-024279

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

Camp4 Therapeutics Corp Filed 2025-09-11 Acc 0001415889-25-024279

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2025-09-15 SCHEDULE 13D/A Beneficial Ownership Report
2025-09-11 4 Chief Financial Officer bought 6,060 shares at $1.65 ($9,999)
2025-09-11 4 Chief Medical Officer bought 6,060 shares at $1.65 ($9,999)
2025-09-11 SCHEDULE 13D/A Beneficial Ownership Report
2025-09-11 SCHEDULE 13D/A Beneficial Ownership Report
2025-09-11 4 10% owner bought 1,307,189 shares at $1.53 ($1,999,999)
2025-09-11 4 Director bought 1,307,189 shares at $1.53 ($1,999,999)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

2026-08-31 SCHEDULE 13D/A · Andrew J. Schwab 9.9%
2026-08-19 SCHEDULE 13D/A · Amir Nashat 6.3%
2026-08-05 SCHEDULE 13D/A · Andrew J. Schwab 9.9%
2026-03-11 SCHEDULE 13D/A · Enavate Sciences GP, LLC 4.8%
2025-12-23 SCHEDULE 13D/A · Enavate Sciences GP, LLC 6.0%

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…